Table 3.
Antifungal susceptibility results of the 79 oral and rectal Candida isolates
| Candida species (no. of isolates) |
% susceptible(MIC range/mg/L) | ||
|---|---|---|---|
| Amphotericin B | Fluconazole | Caspofungein | |
|
C. albicans
(53) |
100 (0.002 - 1.5) |
100 2-16)) |
100 (0.064-1) |
|
C. glabrata
(7) |
100 (0.002 - 0.75) |
71.6* (4-48) |
100 0.25-75)) |
|
C. kefyr
(9) |
100 0.5 - 1.5)) |
100 1.5 - 3)) |
100 (0.125-0.75) |
|
C. tropicalis
(7) |
100 (0.125 - 75) |
100 (2-4) |
100 (0.25-1) |
|
C. parapsilosis
(3) |
100 (0.38-1.0) |
100 (1-6) |
100 (0.5-75) |
* 2/7 of C.glabrata isolates were resistant to fluconazol